BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 20146561)

  • 1. Generation of induced pluripotent stem cells from human adipose-derived stem cells without c-MYC.
    Aoki T; Ohnishi H; Oda Y; Tadokoro M; Sasao M; Kato H; Hattori K; Ohgushi H
    Tissue Eng Part A; 2010 Jul; 16(7):2197-206. PubMed ID: 20146561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
    Zhou W; Freed CR
    Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of induced pluripotent stem cells generated from frozen, stocked bone marrow- and adipose tissue-derived mesenchymal stem cells.
    Ohnishi H; Oda Y; Aoki T; Tadokoro M; Katsube Y; Ohgushi H; Hattori K; Yuba S
    J Tissue Eng Regen Med; 2012 Apr; 6(4):261-71. PubMed ID: 21706774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage.
    Li F; Bronson S; Niyibizi C
    J Cell Biochem; 2010 Mar; 109(4):643-52. PubMed ID: 20039314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel embryonic stem cell line derived from the common marmoset monkey (Callithrix jacchus) exhibiting germ cell-like characteristics.
    Müller T; Fleischmann G; Eildermann K; Mätz-Rensing K; Horn PA; Sasaki E; Behr R
    Hum Reprod; 2009 Jun; 24(6):1359-72. PubMed ID: 19251728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derivation and characterization of canine embryonic stem cell lines with in vitro and in vivo differentiation potential.
    Vaags AK; Rosic-Kablar S; Gartley CJ; Zheng YZ; Chesney A; Villagómez DA; Kruth SA; Hough MR
    Stem Cells; 2009 Feb; 27(2):329-40. PubMed ID: 19038794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term culture following ES-like gene-induced reprogramming elicits an aggressive phenotype in mutated cholangiocellular carcinoma cells.
    Nagai K; Ishii H; Miyoshi N; Hoshino H; Saito T; Sato T; Tomimaru Y; Kobayashi S; Nagano H; Sekimoto M; Doki Y; Mori M
    Biochem Biophys Res Commun; 2010 Apr; 395(2):258-63. PubMed ID: 20381452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of alkaline phosphatase-positive induced pluripotent stem cells from human amniotic fluid-derived cells by feeder-free system.
    Lu HE; Tsai MS; Yang YC; Yuan CC; Wang TH; Lin XZ; Tseng CP; Hwang SM
    Exp Cell Res; 2011 Aug; 317(13):1895-903. PubMed ID: 21640101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.
    Nakagawa M; Koyanagi M; Tanabe K; Takahashi K; Ichisaka T; Aoi T; Okita K; Mochiduki Y; Takizawa N; Yamanaka S
    Nat Biotechnol; 2008 Jan; 26(1):101-6. PubMed ID: 18059259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of pig induced pluripotent stem cells with a drug-inducible system.
    Wu Z; Chen J; Ren J; Bao L; Liao J; Cui C; Rao L; Li H; Gu Y; Dai H; Zhu H; Teng X; Cheng L; Xiao L
    J Mol Cell Biol; 2009 Oct; 1(1):46-54. PubMed ID: 19502222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Induction and characterization of induced pluripotent stem (iPS) cells: a review].
    Cheng D; Lei L; Lu Z; Li Z; Wang H
    Sheng Wu Gong Cheng Xue Bao; 2010 Apr; 26(4):421-30. PubMed ID: 20575428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expansion of human ES and iPS cells on porous membranes and proliferating human adipose-derived feeder cells.
    Hwang ST; Kang SW; Lee SJ; Lee TH; Suh W; Shim SH; Lee DR; Taite LJ; Kim KS; Lee SH
    Biomaterials; 2010 Nov; 31(31):8012-21. PubMed ID: 20674000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53.
    Takenaka C; Nishishita N; Takada N; Jakt LM; Kawamata S
    Exp Hematol; 2010 Feb; 38(2):154-62. PubMed ID: 19922768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and characterization of embryonic stem-like cell lines derived from in vitro fertilization Buffalo (Bubalus bubalis) embryos.
    Huang B; Li T; Wang XL; Xie TS; Lu YQ; da Silva FM; Shi DS
    Reprod Domest Anim; 2010 Feb; 45(1):122-8. PubMed ID: 19144015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reprogramming of adult human neural stem cells into induced pluripotent stem cells.
    Xie LQ; Sun HP; Wang T; Tang HL; Wang P; Zhu JH; Yao ZW; Feng XY
    Chin Med J (Engl); 2013 Mar; 126(6):1138-43. PubMed ID: 23506594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and characterization of rabbit embryonic stem cells.
    Wang S; Tang X; Niu Y; Chen H; Li B; Li T; Zhang X; Hu Z; Zhou Q; Ji W
    Stem Cells; 2007 Feb; 25(2):481-9. PubMed ID: 17038672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast-like cells derived from the gonadal ridges and dorsal mesenteries of human embryos as feeder cells for the culture of human embryonic germ cells.
    He J; Wang Y; Li YL
    J Biomed Sci; 2007 Sep; 14(5):617-28. PubMed ID: 17566873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells.
    Tat PA; Sumer H; Jones KL; Upton K; Verma PJ
    Cell Transplant; 2010; 19(5):525-36. PubMed ID: 20144262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivation of embryonic stem cell line from frozen human embryos and neural differentiation.
    Tan JC; Li Y; Qu WY; Liu LY; Jiang L; Sun KL
    Neuroreport; 2008 Oct; 19(15):1451-5. PubMed ID: 18797296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells.
    Li C; Zhou J; Shi G; Ma Y; Yang Y; Gu J; Yu H; Jin S; Wei Z; Chen F; Jin Y
    Hum Mol Genet; 2009 Nov; 18(22):4340-9. PubMed ID: 19679563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.